Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Non-Current Liabilities (2020 - 2025)

Rockwell Medical (RMTI) has disclosed Total Non-Current Liabilities for 11 consecutive years, with $20.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities fell 26.74% year-over-year to $20.5 million, compared with a TTM value of $20.5 million through Sep 2025, down 26.74%, and an annual FY2024 reading of $25.6 million, down 16.99% over the prior year.
  • Total Non-Current Liabilities was $20.5 million for Q3 2025 at Rockwell Medical, down from $22.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $46.0 million in Q4 2021 and bottomed at $20.5 million in Q3 2025.
  • Average Total Non-Current Liabilities over 5 years is $30.6 million, with a median of $28.2 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities rose 5.62% in 2021, then crashed 33.89% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $46.0 million in 2021, then decreased by 29.32% to $32.5 million in 2022, then fell by 5.11% to $30.9 million in 2023, then decreased by 16.99% to $25.6 million in 2024, then decreased by 20.12% to $20.5 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for RMTI at $20.5 million in Q3 2025, $22.2 million in Q2 2025, and $21.9 million in Q1 2025.